As SLK plays a role in cytoskeletal remodelling, cell migration and heregulin-induced invasion of breast cancer cells [34], we have tested the hypothesis that SLK is required for TGFβ-mediated EMT and the downstream cytoskeletal remodelling necessary to confer the invasive phenotype. The gene discussed is SLK; the disease is breast cancer.